Skip to main content
Journal of Clinical Biochemistry and Nutrition logoLink to Journal of Clinical Biochemistry and Nutrition
. 2018 Jan 19;62(2):167–173. doi: 10.3164/jcbn.17-97

Dietary intake of inorganic phosphorus has a stronger influence on vascular-endothelium function than organic phosphorus

Hiromi Kawamura 1, Sarasa Tanaka 2, Yuri Ota 2, Sumire Endo 2, Mariko Tani 1, Midori Ishitani 1, Motoyoshi Sakaue 1, Mikiko Ito 1,*
PMCID: PMC5874240  PMID: 29610557

Abstract

Phosphorus management through dietetic therapy is vital for the prevention of cardiovascular disease in chronic kidney disease patients. There are two main sources of phosphorus in the diet, organic phosphorus from protein and inorganic phosphorus from food additives. The adverse effects of high phosphorus intake on vascular-endothelium function have been reported; however, the differences in the effects of organic phosphorus versus inorganic phosphorus are not clear. In this study, we examined an acute effect of these high phosphorus meals intake on vascular-endothelium function. This was a randomized, double-blind, cross-over test study design targeting healthy young men. We conducted a food intake test using two test meals, one high in organic phosphorus from organic food sources, and one high in inorganic phosphorus from food additives. Endothelium-dependent vasodilation, phosphorus and calcium in the urine and blood, and phosphorus-related hormones were measured preprandial to 120 min postprandial. The results showed higher serum and urine phosphorus values after the high inorganic phosphorus meal, and a significant reduction in endothelium-dependent vasodilation at 30 min postprandial. These findings are evidence that inorganic phosphorus has a stronger influence on vascular-endothelium function than organic phosphorus.

Keywords: inorganic phosphorus, endothelial function, food additive, flow mediated dilation

Introduction

Elevated serum phosphorus (P) levels have been associated with cardiovascular disease (CVD) and cardiovascular mortality in chronic kidney disease (CKD) patients.(14) Serum P level is mainly regulated by 1,25(OH)2D, a parathyroid hormone (PTH), and fibroblast growth factor 23 (FGF23), and is maintained at 2.5–4.5 mg/dl in healthy populations.(57) The major cause of elevated serum P is excessive P intake under the condition of kidney dysfunction.

P intake from meals is classified into organic P from natural foods and inorganic P from food additives such as pH control agents, coagulants and stabilizers. In healthy people, the rate of absorption of organic P is about 40–60% and that of inorganic P is 90% or more.(8,9) Foods high in protein, such as meat, fish, and dairy products, are major sources of organic P, and it is rare for a P deficiency to develop with the usual dietary pattern of recent years. Rather, there are problems with excessive P uptake since it is used abundantly as an additive in processed foods. When renal function is normal, excessive P is excreted in the urine. However, since the renal function of dialysis patients is inadequate, excretion of P is insufficient, and hyperphosphatemia can easily develop.(8,10)

Hyperphosphatemia has been associated with arteriosclerosis and vascular calcification, and is an important factor in the onset of CVD in dialysis patients.(14) Therefore, P management through dietetic therapy is important for dialysis patients.(11) However, the high amounts of inorganic P found in food additives make P management difficult. In addition, there are no standardized criteria for inorganic P on food packaging labels in Japan and food manufacturers are under no obligation to provide this information, making it very difficult to ascertain the amount of P intake.

The dysfunction of vascular endothelial cells is an important effect of hyperphosphatemia.(12) Vascular endothelial cells exist in the innermost layer of a vessel, and emit various substances essential to vessel operation, such as nitric oxide (NO), endothelin, C-type natriuretic peptide, and prostaglandin I2.(13) Moreover, NO controls the cohesion and flocculation of thromboplastids, functions that protect vessels by preventing blood coagulation.(12) It has been reported that a high P state causes an incremental increase in oxidative stress, a reduction in NO yield in systemic endotheliocytes, and induces an apoptotic state in CKD patients.(1416) When damage to endotheliocytes continues over the long term, the protective effect of a vessel fails and CVD due to arteriosclerosis develops.

A previous report investigated the influence of transient P intake by studying the effects of low and high P loading (meals with 400 and 1,200 mg, respectively) on vascular-endothelium function in healthy men using a P loading test for inorganic P.(17) The results showed serum P levels were elevated after a high P intake, and serum P level and vascular-endothelium function had a negative relationship. These results are evidence that P from oral intake increases serum P concentration and affects vascular-endothelium function.

In this study, we hypothesized that inorganic P has a stronger influence on vascular-endothelium function than organic P and is connected with CVD. We investigated the differences in phosphate metabolism and the effects of consuming meals high in organic P and inorganic P on vascular-endothelium function.

Materials and Methods

Subjects

We conducted a food intake test for organic and inorganic P in ten healthy young men without hypertony, smoking history, present illness, or prescription history of vascular-endothelium function-related drugs or antioxidation supplements. The study protocols were approved by the Ethics Committee of the University of Hyogo. Signed written informed consent was obtained from all study subjects before participation. We finally chose six subjects, except men who exceeded standard level of preprandial serum P levels, FGF23 or endothelium-dependent vasodilation. The preprandial characteristics of the six subjects are shown in Table 1. This intake test did same six subjects eat both meals with a 7-day break in between.

Table 1.

Baseline characteristics of the study subjects

Characteristic Mean ± SE
Age (year) 20.3 ± 0.4
Height (cm) 172.5 ± 2.8
Weight (kg) 61.8 ± 3.1
Percent of body fat (%) 14.6 ± 1.6
Lean body mass (kg) 52.6 ± 2.0
BMI (kg/m2) 20.7 ± 0.6
Systolic blood pressure (mmHg) 104.3 ± 1.0
Diastolic blood pressure (mmHg) 59.5 ± 3.0
Pulse (bpm) 74.2 ± 5.4

Measurements of stature, weight, percent body fat, lean body mass, and body mass index (BMI) were taken using a digital stature meter AD-6400 (A&D Company, Ltd. Tokyo, Japan) or InBody720 Body Composition Analyzer (InBody Japan Inc., Tokyo, Japan). Measurements of blood pressure and pulse were performed using a fully automatic sphygmomanometer TM-265 (A&D Company, Ltd.) before the first food intake test.

Study design

The study used a randomized, double-blind, crossover design on two different days separated by at least 7 days. The protocol is illustrated diagrammatically in Fig. 1. In order to eliminate various factors that could affect the measurements, dinner on the day preceding the food intake test for all subjects was a standard meal eaten from 19:00 to 20:00 and then only water was consumed until 24:00. The standard dinner consisted of 755 kcal with 16.1 g of protein, 163 mg of calcium (Ca) and 180 mg of P.

Fig. 1.

Fig. 1

Study schema. On the day before the test, all subjects ate a standard meal at 19:00–20:00 and were asked to consume only water after eating. The subjects came to the laboratory in a fasted state and were allowed to drink water after the test meal. We measured %FMD and collected blood and urine samples (▲) at four time points: preprandial (0 min) and 30, 60 and 120 min postprandial. We also took anthropometric measurements and blood pressure at 0 min for the first meal only.

The subjects came to the laboratory at 08:30 after fasting from 24:00 the previous night and rested in a seated position for about 30 min in a room maintained at 25°C. The two test meals were served in random order. The food intake test was completed within 15 min, and subjects could drink freely thereafter. Measurements were performed for each test meal preprandial (0 min) and postprandial (30, 60 and 120 min). Measurements for body composition elements, blood pressure, and pulse were taken at 0 min only for the first meal. Vascular-endothelium function was measured as described below, and urine and blood were collected at all four time points.

The composition of the test meals is shown in Table 2. The high organic P meal containing organic P (1,200 mg) was prepared using natural food sources. The high inorganic P meal contained inorganic P from food additives (1,000 mg) and organic P (199.7 mg) from natural food sources. Nutritional information values were computed using the Standard Tables of Food Composition in japan 2010. Both test meals consisted of approximately 860 kcal with 31 g of protein, 1,200 mg of P (both organic and inorganic), and 490 mg of Ca. The P loading amount was chosen with reference to a preceding study.(17) The upper limit (3,000 mg/day) according to the Japanese Dietary Reference Intake 2015 edition was taken into consideration as an amount which does not cause harm to health, and the appropriate P load was determined to be 1,200 mg.

Table 2.

Composition of test meals

Weight (g) Energy (kcal) Protein (g) Fat (g) Carbohydrate (g) P (mg) Ca (mg)
High organic P meal
 Brown rice 130 455 8.8 3.5 95.9 377 12
 Dried egg yolk 23 167 7.0 14.5 0.0 230 64
 Non-fat dried milk 35 126 11.9 0.4 18.7 350 385
 Seasoned laver 10 18 4.0 0.4 4.2 71 17
 Gelation agent 30 99 0.0 0.1 27.4 174 12
 Total 864 31.7 18.7 146.2 1,202 490

High inorganic P meal

 Milled rice 130 463 7.9 1.2 100.2 122 7
 Dried egg yolk 5 36 1.5 3.1 0.0 50 14
 Dried egg albumen 25 95 21.6 0.1 0.1 28 15
 Salad oil 29 267 0.0 29.0 0.0 0 0
 Salt 1 0 0.0 0.0 0.0 0 0
 Additive P 1 0 0.0 0.0 0.0 1,000 0
 Additive Ca 0.5 0 0.0 0.0 0.0 0 454

 Total 861 31.1 33.4 100.3 1,200 490

Biochemical determination

Blood samples were collected from the median cubital vein at four time points: preprandial (0 min), and 30, 60 and 120 min postprandial. P, Ca, 1,25(OH)2D, and intact PTH were measured at all four time points. Ionized Ca, high density lipoprotein cholesterol (HDL-C), low density lipoprotein cholesterol (LDL-C), triglycerides (TG), uric acid (UA), sodium (Na), chloride (Cl), and potassium (K) were measured at three points (0–60 min postprandial). All blood test measurements were performed by Hyogo Clinical Laboratory Corporation (Hyogo, Japan). Blood glucose level was measured at all four time points using the Glutest Neo Super blood glucose meter (Sanwa Kagaku Kenkyusyo Co., Ltd., Aichi, Japan) at the time a blood sample was collected. Serum FGF23 concentration was measured using FGF-23 ELISA Kit (Kainos Laboratories, Inc., Tokyo, Japan).

Urine was also collected at all four time points: preprandial (0 min) and 30, 60 and 120 min postprandial. Urine P, Ca and creatinine were measured at all four points. Urine pH, protein, sugar, urobilinogen, occult blood, bilirubin, and ketone bodies were measured at 0 min. All urine test measurements were performed by Hyogo Clinical Laboratory Corporation. Creatinine corrections were calculated for urine P and Ca concentrations in order to eliminate the influence of water intake or sweating.

Measurement of endothelium-dependent vasodilation

We evaluated endothelial function by measuring flow mediated dilation (FMD; UNEXEF18VG, UNEX Corporation, Aichi, Japan), according to previously published guidelines.(18,19) %FMD was measured at four time points: preprandial (0 min) and 30, 60 and 120 min postprandial. If vascular-endothelium function damage occurs, the NO yield and %FMD value will decrease. Generally, the lumen diameter method is used to determine the diameter of a vessel. However, since the subjects of this study were young, the tunica-intima tunica-media composite thickness was thin, and therefore difficult to determine.(20) Instead, we estimated vessel diameter using the diameter between tunica externas for which clear imaging was obtained. The normal diameter measurement between lining membranes is 6% or more; however, using the diameter between tunica externas, the denominator and resting vessel diameter are large, and the %FMD value is determined to be low at about 1%.(21)

The %FMD value at each of the three postprandial times was indicated by lumen the rate of change from the preprandial value at 0 min since the preprandial %FMD value varies between individuals.

Statistical analysis

The distribution of basic characteristic values, hematometry values, urine analysis values, %FMD values, and the %FMD rate of change was tested using the Shapiro-Wilk test. Verification of the differences between the two meals were determined following quantitative datum using the t test or Mann-Whitney U test for variables with a normal distribution. Results for items with a normal distribution are shown as mean ± SD, and/or median (minimum-maximum). We used IBM SPSS Statistics ver. 21.0 for all data analyses and statistical significance was set at less than 5%.

Results

Preprandial characteristics of subjects

The basic characteristics of the subjects (n = 6) before consuming the first test meal are shown in Table 1. The results of hematometry and %FMD measurements are shown in Table 3. Almost all hematometry values were within the normal range. The urine analysis results are shown in Table 4. All urine analysis values were within the normal range. No significant differences in any of these factors were seen before consuming the high organic P and the high inorganic P test meals.

Table 3.

Preprandial serum chemistry and %FMD findings

Normal range High organic P meal High inorganic P meal p
%FMD 6≤ 7.1 ± 0.5 6.9 ± 0.6
UA (mg/dl) 3.6–7.0 6.1 ± 0.3 5.9 ± 0.2 0.569
Glucose (mg/dl) <100 93.2 ± 1.5 88.5 ± 1.8 0.080
TG (mg/dl) 40–149 135.8 ± 29 101.8 ± 10.0 0.688
HDL-Cho (mg/dl) 41–86 56.3 ± 4.7 60 ± 5.5 0.623
LDL-Cho (mg/dl) 70–139 100.0 (67–183) 107.5 (87–182) 0.200
LDL/HDL ratio 1.64 (1.02–4.58) 1.67 (1.33–4.33) 1.000
Na (mEq/L) 135–150 140.3 ± 0.8 141.7 ± 0.3 0.169
K (mEq/L) 3.3–4.8 4.7 ± 0.3 4.5 ± 0.1 0.636
Cl (mEq/L) 98–108 101.7 ± 0.7 102.0 (97–103) 0.886
Ca (mg/dl) 8.4–10.2 9.4 ± 0.1 9.7 ± 0.1 0.171
Ionized Ca (mEq/L) 2.41–2.72 2.48 ± 0 2.52 ± 0 0.469
P (mg/dl) 2.5–4.5 3.6 ± 0.2 3.5 ± 0.1 0.926
intact PTH (pg/ml) 15.0–70.0 24.4 ± 2.5 27.5 ± 2.5 0.399
1,25(OH)2D (pg/ml) 20–60 66.2 ± 9.2 63 ± 9.7 0.983
FGF23 (pg/ml) 10–50 56.6 ± 6.6 59.8 ± 3.8 0.708

Values are mean ± SE or median (minimum–maximum).

Table 4.

Preprandial urinary chemistry findings

High organic P meal High inorganic P meal
Cre (mg/dl) 257.8 (228.2–585.5) 241.7 ± 54.0
Ca (mg/dl) 14.4 ± 3.5 6.0 (2.9–36.0)
Ca/Cre 0.07 ± 0.02 0.05 ± 0.02
P (mg/dl) 50.3 (43.0–112.5) 64.3 ± 13.9
P/Cre 0.20 (0.16–0.21) 0.24 (0.22–0.39)
Urinary volume (ml) 48.2 ± 10.0 80.0 (30.0–440.0)
pH 5.9 ± 0.3 6.3 ± 0.4
Protein (−) (−)
Glucose (−) (−)
Urobilinogen (±) (±)
Occult blood (−) (−)
Bilirubin (−) (−)
Ketone body (−) (−)

Values are mean ± SE or median (minimum-maximum).

Influence on phosphorus metabolism

As for HDL-C, LDL-C, the LDL/HDL ratio, TG, UA, Na, Cl, K and blood glucose level, no significant difference was seen between the two test meals at any of the time points. Changes in serum P, Ca and ionized Ca over time are shown in Fig. 2. Serum P significantly increased after the high inorganic P meal at 30, 60 and 120 min postprandial compared with preprandial (p<0.05, p<0.01 and p<0.001, respectively). On the other hand, a significant postprandial change was not seen after the high organic P meal. When comparing the two test meals, the high inorganic P meal resulted in higher serum P at all time points than the high organic P meal. There were no significant changes in serum Ca and ionized Ca (data not shown) at any of the postprandial time points with either of the two test meals, and there were no significant differences between the two test meals.

Fig. 2.

Fig. 2

Changes in serum P (A) and serum Ca (B) over time. The white circles indicate the high organic P meal and the black circles indicate the high inorganic P meal. *p<0.05, **p<0.01 (n = 6).

Changes in urine P and Ca over time are shown in Fig. 3. Urine P showed a higher level of significance after the high inorganic P meal compared with the high organic P meal 60 and 120 min postprandial. Urine Ca showed an upward tendency postprandial after both test meals, but the difference was not significant.

Fig. 3.

Fig. 3

Changes in urine P/creatinine (A) and urine Ca/creatinine (B) over time. The white circles indicate the high organic P meal and the black circles indicate the high inorganic P meal. *p<0.05, **p<0.01 (n = 6).

Changes in phosphate metabolism regulation hormones in the blood over time are shown in Fig. 4. The 1,25(OH)2D, intact PTH and FGF23 levels did not show any significant differences between the two test meals at any of the time points.

Fig. 4.

Fig. 4

Changes in the P metabolism regulating hormones serum 1,25(OH)2D (A), serum intact PTH (B) and serum FGF23 (C) over time. The white circles indicate the high organic P meal and the black circles indicate the high inorganic P meal (n = 6).

Effect on vascular-endothelium function

Changes in %FMD values over time are shown in Fig. 5. %FMD values showed reductions after both test meals at 30 min postprandial. After 30 min postprandial, %FMD values gradually rose and had mostly recovered to preprandial levels by 120 min postprandial (Fig. 5A). After the high organic P meal, a significant reduction was seen at 30 min postprandial compared with preprandial (p<0.05). However, %FMD values after the high inorganic P meal showed significant reductions at 30 and 60 min postprandial (p<0.01 and p<0.05, respectively). A tendency for %FMD to remain reduced was observed after the high inorganic P meal compared with the high organic P meal.

Fig. 5.

Fig. 5

Influence of organic and inorganic P meals on endothelial function over time. Time course of %FMD (A) and relative change of %FMD (B) from preprandial. The white circles indicate the high organic P meal and the black circles indicate the high inorganic P meal. *p<0.05 (n = 6).

Furthermore, since individual differences were seen at preprandial, postprandial %FMD values are shown as the %FMD rate of change (Fig. 5B). The rate of change after the high inorganic P meal at 30 min postprandial (–20.0%) was significantly lower than that of the high organic P meal (–10.1%) (p = 0.024).

Discussion

We investigated the influence of two different forms of P on vascular-endothelium function and found that high inorganic P meals resulted in elevated serum and urine P levels, and reduced %FMD values compared with high organic P meals. Therefore, it became clear that inorganic P has a stronger influence on vascular-endothelium function than organic P in healthy young men.

A reduction in vascular-endothelium function is one of the initial complications of arterial sclerosis. Factors such as diet, age, level of physical activity, and smoking have been reported to influence vascular-endothelium function.(22,23) As for dietary factors, a high sugar foods, and high salinity foods, high fat diet have been reported to reduce vascular-endothelium function.(2426) These dietary factors increase oxidative stress and lead to vascular endothelial cell damage, through the activity reduction of endothelial NO synthase (eNOS) by a reactive oxygen species.

On the other hand, it has been reported that vascular-endothelium function is improved by the uptake of polyphenolics, such as a cocoa flavonol and curcumin.(27,28) Polyphenolics have antioxidant properties and are known to control the reduction of vascular-endothelium function by reducing oxidative stress. Thus, vascular-endothelium function is subject to the influence of temporary sensitivity to dietary factors. The accumulation of these effects is considered to be related to the development or prevention of arterial sclerosis.

One study of dietary P and vascular-endothelium function in healthy men showed elevated serum P levels and reduced %FMD values after the intake of meals high in inorganic P.(17) Furthermore, it has been shown that serum P levels and %FMD values have a negative correlation. In accordance with the elevation of serum P, oxidative stress increases, NO yield falls, and inorganic P stress is caused by damage to the vascular-endothelium function being carried out. Furthermore, it was assumed that inorganic P reduced %FMD values even though the amount of P loading was equivalent because the rate of absorption of inorganic P is higher than that of organic P.

One of the strengths of this study is that it shows the influence of two different forms of P on the reduction of vascular-endothelium function for the first time. It is thought that the regulatory mechanism through urinary excretion functioned because an elevation in urine P level was shown with an elevation in serum P level. Moreover, the alteration of phosphate metabolism in this study was temporary, so it did not influence P regulation hormones.

One limitation of this study is that there were few subjects. Although there were many subjects at the start of the study, those with serum P, FGF23 and %FMD values over the standard level were excluded. The subjects were also healthy young men, so the fact that many of them showed values exceeding the standards may reflect excessive P uptake in the current Japanese society.

In dialysis patients, hyperphosphatemia can induce vascular-endothelium damage. It is suggested that the long-term effects of this damage influence to arterial sclerosis, vascular calcification, and the development of CVD. In this study, the elevation of serum P after high inorganic P meal was normal range, and the reduction of %FMD had for the most part recovered by 120 min postprandial. However, it is thought that a habitual overabundant intake of inorganic P may cause dysfunction of the vascular endothelium in healthy persons by repeating the transient damage to the endothelial cells.

It has been reported that a reduction in renal function and a reduction in %FMD values are related, and dialysis patients have low %FMD values compared with healthy persons.(29,30) It has been also reported that %FMD is decreased by indoxyl sulfate, a protein-bound uremic toxin, and leptin, which is elevated in CKD patients.(31,32) Thus, P is one of the factors relevant to CVD, and this study showed that P, notably inorganic P, management in the diet is important. However, there are reports that only 17.8% of non-dialysis CKD patients in Japan did not know that inorganic phosphorus was contained in processed foods or drinks.(33) In addition, 68.9% of patients did not know that excessive intake of phosphorus would harm. 37% of CKD patients who begin dialysis already have cardiovascular events.(34) Thus, education about phosphorus intake is necessary form the early stage of CKD patients. The amounts of phosphorus in nutrition facts label of foods, in particular processed foods, is considered to be needed for patients to select foods.

In this study, it became evident that inorganic P contained in food additives has a strong effect on vascular-endothelium function and contributes to the development of CVD. Therefore, it is recommended that excessive intake of processed foods with high amounts of inorganic P be avoided. Further study of the factors that prevent the impact of inorganic P will lead to improvements in dietary management for dialysis patients and prevention of CVD.

Acknowledgments

This study was supported in part by a Grant-in-Aid for Scientific Research from the Japan Society for the Promotion for Science (No. 25282025 and 16H03048 to MS).

Abbreviations

BMI

body mass index

Ca

calcium

CKD

chronic kidney disease

Cl

chloride

Cre

creatinine

CVD

cardiovascular disease

FGF23

fibroblast growth factor 23

FMD

flow mediated dilation

HDL-C

high density lipoprotein cholesterol

K

potassium

LDL-C

low density lipoprotein cholesterol

Na

sodium

NO

nitric oxide

P

phosphorus

PTH

parathyroid hormone

TG

triglyceride

UA

uric acid

Conflict of Interest

No potential conflicts of interest were disclosed.

References

  • 1.Schwarz S, Trivedi BK, Kalantar-Zadeh K, Kovesdy CP. Association of disorders in mineral metabolism with progression of chronic kidney disease. Clin J Am Soc Nephrol. 2006;1:825–831. doi: 10.2215/CJN.02101205. [DOI] [PubMed] [Google Scholar]
  • 2.Adeney KL, Siscovick DS, Ix JH, et al. Association of serum phosphate with vascular and valvular calcification in moderate CKD. J Am Soc Nephrol. 2009;20:381–387. doi: 10.1681/ASN.2008040349. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Chue CD, Edwards NC, Moody WE, Steeds RP, Townend JN, Ferro CJ. Serum phosphate is associated with left ventricular mass in patients with chronic kidney disease: a cardiac magnetic resonance study. Heart. 2012;98:219–224. doi: 10.1136/heartjnl-2011-300570. [DOI] [PubMed] [Google Scholar]
  • 4.Eddington H, Hoefield R, Sinha S, et al. Serum phosphate and mortality in patients with chronic kidney disease. Clin J Am Soc Nephrol. 2010;5:2251–2257. doi: 10.2215/CJN.00810110. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Bergwitz C, Juppner H. Regulation of phosphate homeostasis by PTH, vitamin D, and FGF23. Annu Rev Med. 2010;61:91–104. doi: 10.1146/annurev.med.051308.111339. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Kaneko I, Tatsumi S, Segawa H, Miyamoto KI. Control of phosphate balance by the kidney and intestine. Clin Exp Nephrol. 2017;21(Suppl 1):21–26. doi: 10.1007/s10157-016-1359-4. [DOI] [PubMed] [Google Scholar]
  • 7.Vervloet MG, Sezer S, Massy ZA, et al. The role of phosphate in kidney disease. Nat Rev Nephrol. 2017;13:27–38. doi: 10.1038/nrneph.2016.164. [DOI] [PubMed] [Google Scholar]
  • 8.Sullivan CM, Leon JB, Sehgal AR. Phosphorus-containing food additives and the accuracy of nutrient databases: implications for renal patients. J Ren Nutr. 2007;17:350–354. doi: 10.1053/j.jrn.2007.05.008. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Ritz E, Hahn K, Ketteler M, Kuhlmann MK, Mann J. Phosphate additives in food—a health risk. Dtsch Arztebl Int. 2012;109:49–55. doi: 10.3238/arztebl.2012.0049. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Benini O, D'Alessandro C, Gianfaldoni D, Cupisti A. Extra-phosphate load from food additives in commonly eaten foods: a real and insidious danger for renal patients. J Ren Nutr. 2011;21:303–308. doi: 10.1053/j.jrn.2010.06.021. [DOI] [PubMed] [Google Scholar]
  • 11.Japanese Society of Nephrology. Dietary recommendations for chronic kidney disease, 2014. Nihon Jinzo Gakkai Shi. 2014;56:553–599. (in Japanese) [PubMed] [Google Scholar]
  • 12.Higashi Y, Noma K, Yoshizumi M, Kihara Y. Endothelial function and oxidative stress in cardiovascular diseases. Circ J. 2009;73:411–418. doi: 10.1253/circj.cj-08-1102. [DOI] [PubMed] [Google Scholar]
  • 13.Vanhoutte PM. Endothelium and control of vascular function. State of the Art lecture. Hypertension. 1989;13 (6 Pt 2):658–667. doi: 10.1161/01.hyp.13.6.658. [DOI] [PubMed] [Google Scholar]
  • 14.Kendrick J, Chonchol M. The role of phosphorus in the development and progression of vascular calcification. Am J Kidney Dis. 2011;58:826–834. doi: 10.1053/j.ajkd.2011.07.020. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Martens CR, Edwards DG. Peripheral vascular dysfunction in chronic kidney disease. Cardiol Res Pract. 2011;2011:267257. doi: 10.4061/2011/267257. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Baylis C. Nitric oxide deficiency in chronic kidney disease. Am J Physiol Renal Physiol. 2008;294:F1–F9. doi: 10.1152/ajprenal.00424.2007. [DOI] [PubMed] [Google Scholar]
  • 17.Shuto E, Taketani Y, Tanaka R, et al. Dietary phosphorus acutely impairs endothelial function. J Am Soc Nephrol. 2009;20:1504–1512. doi: 10.1681/ASN.2008101106. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Deanfield JE, Halcox JP, Rabelink TJ. Endothelial function and dysfunction: testing and clinical relevance. Circulation. 2007;115:1285–1295. doi: 10.1161/CIRCULATIONAHA.106.652859. [DOI] [PubMed] [Google Scholar]
  • 19.Corretti MC, Anderson TJ, Benjamin EJ, et al. Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the International Brachial Artery Reactivity Task Force. J Am Coll Cardiol. 2002;39:257–265. doi: 10.1016/s0735-1097(01)01746-6. [DOI] [PubMed] [Google Scholar]
  • 20.JCS Joint Working Group. Guidelines for diagnosis and treatment of patients with vasospastic angina (Coronary Spastic Angina) (JCS 2013). Circ J. 2014;78:2779–2801. doi: 10.1253/circj.cj-66-0098. [DOI] [PubMed] [Google Scholar]
  • 21.Jarvisalo MJ, Jartti L, Toikka JO, Hartiala JJ, Rönnemaa T, Raitakari OT. Noninvasive assessment of brachial artery endothelial function with digital ultrasound and 13-MHz scanning frequency: feasibility of measuring the true inner luminal diameter using the intima-lumen interface. Ultrasound Med Biol. 2000;26:1257–1260. doi: 10.1016/s0301-5629(00)00308-2. [DOI] [PubMed] [Google Scholar]
  • 22.Black MA, Cable NT, Thijssen DH, Green DJ. Impact of age, sex, and exercise on brachial artery flow-mediated dilatation. Am J Physiol Heart Circ Physiol. 2009;297:H1109–H1116. doi: 10.1152/ajpheart.00226.2009. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Celermajer DS, Sorensen KE, Georgakopoulos D, et al. Cigarette smoking is associated with dose-related and potentially reversible impairment of endothelium-dependent dilation in healthy young adults. Circulation. 1993;88 (5 Pt 1):2149–2155. doi: 10.1161/01.cir.88.5.2149. [DOI] [PubMed] [Google Scholar]
  • 24.Vogel RA, Corretti MC, Plotnick GD. Effect of a single high-fat meal on endothelial function in healthy subjects. Am J Cardiol. 1997;79:350–354. doi: 10.1016/s0002-9149(96)00760-6. [DOI] [PubMed] [Google Scholar]
  • 25.Kawano H, Motoyama T, Hirashima O, et al. Hyperglycemia rapidly suppresses flow-mediated endothelium-dependent vasodilation of brachial artery. J Am Coll Cardiol. 1999;34:146–154. doi: 10.1016/s0735-1097(99)00168-0. [DOI] [PubMed] [Google Scholar]
  • 26.Dickinson KM, Clifton PM, Keogh JB. Endothelial function is impaired after a high-salt meal in healthy subjects. Am J Clin Nutr. 2011;93:500–505. doi: 10.3945/ajcn.110.006155. [DOI] [PubMed] [Google Scholar]
  • 27.Schroeter H, Heiss C, Balzer J, et al. (−)-Epicatechin mediates beneficial effects of flavanol-rich cocoa on vascular function in humans. Proc Natl Acad Sci U S A. 2006;103:1024–1029. doi: 10.1073/pnas.0510168103. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Nakayama H, Tsuge N, Sawada H, et al. A single consumption of curry improved postprandial endothelial function in healthy male subjects: a randomized, controlled crossover trial. Nutr J. 2014;13:67. doi: 10.1186/1475-2891-13-67. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Miyagi T, Kohagura K, Ishiki T, et al. Interrelationship between brachial artery function and renal small artery sclerosis in chronic kidney disease. Hypertens Res. 2014;37:863–869. doi: 10.1038/hr.2014.60. [DOI] [PubMed] [Google Scholar]
  • 30.Ghiadoni L, Cupisti A, Huang Y, et al. Endothelial dysfunction and oxidative stress in chronic renal failure. J Nephrol. 2004;17:512–519. [PubMed] [Google Scholar]
  • 31.Lin CJ, Wu CJ, Wu PC, et al. Indoxyl sulfate impairs endothelial progenitor cells and might contribute to vascular dysfunction in patients with chronic kidney disease. Kidney Blood Press Res. 2016;41:1025–1036. doi: 10.1159/000452604. [DOI] [PubMed] [Google Scholar]
  • 32.Ding N, Liu B, Song J, et al. Leptin promotes endothelial dysfunction in chronic kidney disease through AKT/GSK3β and β-catenin signals. Biochem Biophys Res Commun. 2016;480:544–551. doi: 10.1016/j.bbrc.2016.10.079. [DOI] [PubMed] [Google Scholar]
  • 33.Shutto Y, Yamabe H, Shimada M, Murakami R, Fujita T, Nakamura N. Lack of awareness of phosphate in processed food and drinks among patients with chronic kidney disease. Prog Med. 2013;33:2255–2259. [Google Scholar]
  • 34.Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med. 2004;351:1296–1305. doi: 10.1056/NEJMoa041031. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Biochemistry and Nutrition are provided here courtesy of The Society for Free Radical Research Japan

RESOURCES